Drug deaths are down in one Ohio county and much of the US
UC College of Nursing professor discusses the impact of fentanyl
The Washington Post recently published a story discussing Hamilton County’s successes in battling the opioid crisis. That journey in many ways parallels the nation’s experience at the start of 2025.
The Post reports that drug deaths fueled primarily by illicit fentanyl reached staggering heights by 2023, topping 100,000 for the third straight year. But in the 12-month period ending in August, deaths had decreased by more than 20 percent from the same period the previous year, according to provisional state data published by the Centers for Disease Control and Prevention. Although the CDC won’t publish 2024 estimates for several months, experts say there could be more than 20,000 fewer deaths than the year before.
The newspaper spoke with families who lost loved ones and others who survived opioid addiction along with first-responders and community agencies that were among the first line of defense. Tasha Turner-Bicknell, an associate professor of nursing at UC, and a board member of Harm Reduction Ohio also weighed in on the discussion and spoke with the Post. Harm Reduction Ohio supplies free naloxone to a network of distributors on the streets.
Tasha Turner-Bicknell, associate professor at the UC College of Nursing
“I would add that these numbers are encouraging and demonstrate that harm reduction saves lives,” says Turner-Bicknell, who is also director of advanced public health nursing DNP and certificate programs at UC. “We still have a lot of work to do. We need to continue to strengthen and expand harm reduction programs to meet people where they are and offer them the support services they need.”
The Post reports that government officials, researchers and public health organizations have puzzled over the reasons but speculate a decline in deaths represents a confluence of factors that vary regionally. The Biden administration made Narcan, a nasal spray version of the overdose-reversal medication naloxone, available without a prescription and broadened access to medications to treat opioid addiction. Officials touted crackdowns on Mexican criminal groups that manufacture fentanyl and Chinese companies that supply them with chemicals needed to make the opioid.
Read the full story in The Washington Post online.
Learn more about Tasha Turner-Bicknell online.
Related Stories
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
Pocket-sized population threat
May 18, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.